| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |